News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

St. Jude Medical (STJ)'s Durata Defibrillator "Immune" to Riata Flaws?


6/19/2013 8:06:33 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

St. Jude Medical's Durata implantable cardiac defibrillator leads should be "relatively immune" to the problems that led to a recall for the medical device company's Riata ICD leads, according to a cardiologist who helped bring the Riata problems to light. St. Jude Medical (NYSE:STJ) pulled its Riata implantable cardiac defibrillator leads in 2010 after mounting evidence suggested that the Riata leads were prone to abrading through their insulation. The move cast a pall over over St. Jude's newer ICD lead offerings, the Riata ST Optim and Durata leads.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES